Adolescent Choline Supplementation Attenuates Working Memory Deficits in Rats Exposed to Alcohol During the Third

Ronald D Schneider1, Jennifer D Thomas1

  • 1Department of Psychology (RDS, JDT), Center for Behavioral Teratology, San Diego State University, San Diego, California.

Insights

Adolescent choline supplementation partially mitigated behavioral deficits from prenatal alcohol exposure in rats. This dietary intervention shows promise for treating some fetal alcohol spectrum disorder effects later in life.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Nutritional Science

Background:

  • Prenatal alcohol exposure can cause lifelong behavioral and cognitive deficits.
  • Choline supplementation during development may counteract some alcohol-induced effects.
  • The efficacy of late-stage choline administration for mitigating prenatal alcohol exposure consequences is not well understood.

Purpose of the Study:

  • To investigate if choline supplementation during adolescence/young adulthood can reduce the adverse effects of prenatal alcohol exposure.
  • To determine the impact of late-stage choline administration on behavioral and cognitive outcomes in a rodent model.

Main Methods:

  • Sprague-Dawley rats received alcohol during brain development (postnatal days 4-9).
  • Choline chloride or vehicle was administered during adolescence/young adulthood (postnatal days 40-60).
  • Behavioral testing included open field activity, spatial learning (Morris water maze), and spatial working memory.

Main Results:

  • Alcohol-exposed rats exhibited hyperactivity and impaired spatial learning and working memory.
  • Choline treatment did not improve activity levels or spatial learning.
  • Choline supplementation significantly improved spatial working memory, suggesting prefrontal cortex involvement.

Conclusions:

  • Adolescent choline supplementation can attenuate specific behavioral deficits caused by prenatal alcohol exposure.
  • Dietary interventions with choline may offer therapeutic benefits for individuals with fetal alcohol spectrum disorders, even when initiated later in life.
Abstract

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
812
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K